545 results on '"Scotlandi, K."'
Search Results
2. SELNET clinical practice guidelines for bone sarcoma
3. Corrigendum to “SELNET clinical practice guidelines for soft tissue sarcoma and GIST” [Cancer Treat. Rev. 102 (2021) 102312]
4. Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome
5. Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression
6. Corrigendum to “SELNET clinical practice guidelines for bone sarcoma” Critical reviews in oncology/hematology, vol. 174 (2022), 1–10
7. Targeted Therapies in Ewing's Sarcoma
8. Prognostic and Therapeutic Targets in the Ewing's Family of Tumors (PROTHETS)
9. CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling
10. Fractal Analysis of Chromatin during Apoptosis
11. Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?
12. SELNET clinical practice guidelines for soft tissue sarcoma and GIST
13. CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity
14. Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy
15. Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma
16. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma
17. 1962P phase II study for nonmetastatic extremity high-grade osteosarcoma in pediatric and AYA patients with a risk-adapted strategy based on P-glycoprotein expression by the ISG (ISG/OS-2): A correlative study on tumor microenvironment
18. Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma
19. Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling
20. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma
21. Correction to: Cell communication and signaling: How to turn bad language into positive one (Journal of Experimental and Clinical Cancer Research DOI: 10.1186/s13046-019-1122-2)
22. Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion
23. CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity
24. 2.O.03 PROGNOSIS AND THERAPEUTIC TARGETS IN THE EWING FAMILY OF TUMOURS - 6TH FRAMEWORK PROGRAMME
25. Zyxin in Ewing sarcoma: a novel role as mediator between CD99 and EWS-FLI1
26. The role of zyxin as a mediator between CD99 and EWS-FLI1
27. Targeted Therapies in Ewing's Sarcoma
28. Prognostic and Therapeutic Targets in the Ewing's Family of Tumors (PROTHETS)
29. Anticancer Effects of Zoledronic Acid against Human Osteosarcoma Cells
30. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells
31. Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma
32. Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients
33. ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents
34. Simultaneous Paired Analysis of Numerical Chromosomal Aberrations and DNA Content in Osteosarcoma
35. Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase gene
36. Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients
37. Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases
38. miRNA signature predicts survival of Ewing’s sarcoma patients and miR34a directly influences cell chemosensitivity and malignancy
39. The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report
40. Copy Number Alterations and Neoplasia-Specific Mutations in MELK, PDCD1LG2, TLN1, and PAX5 at 9p in Different Neoplasias
41. May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian /Scandinavian Sarcoma Group 1 treatment protocol
42. PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma
43. Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells
44. Late abstracts 186–187
45. Molecular properties and antiproliferative activity against tumor cells of a new poly-alkylamino-bis-maltolic synthetic molecule (maltonis)
46. Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells
47. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors
48. CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling
49. CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients
50. Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.